Inflammatory bowel disease has long asked patients to give blood and stool samples in order to learn what is happening inside the gut, and a team led by Sarah Shahub has now asked whether the body's sweat might carry the same message. In a small study of 33 people, reported in Inflammatory Bowel Diseases, a patch worn against the skin sampled perspiration and tracked two familiar signals of inflammation, C-reactive protein and calprotectin, and the readings broadly matched what blood and stool tests showed. It is a modest first step, one that hints at a future in which the quiet chemistry of s
Wearable Perspiration Sensor Shows Promise for Continuous Inflammation Tracking in IBD
Sweat, sampled once every 60 seconds, as a window into gut inflammation
Mark
So what is actually new here? We already measure CRP and calprotectin.
Mimi
The sampling. Blood and stool give a snapshot. This sensor takes a reading from sweat every 60 seconds, so it points toward continuous tracking without a needle or a stool sample.
Mark
And it worked?
Mimi
The authors say sweat CRP and calprotectin were consistent with serum and stool values. Wear times ran from 40 to 130 minutes.
Luke
Careful with "worked." That's the investigators' conclusion about consistency. The summary here doesn't give correlation figures or error rates, so I can't tell you how close the match was.
Mark
There were differences by disease type, too.
Mimi
Yes. Crohn's patients had higher median CRP, ulcerative colitis patients higher calprotectin. Colonic disease showed higher calprotectin than isolated ileal disease.
Luke
Those are medians in 33 people, split into subgroups. Small groups. And stool samples came from only a subcohort, so the sweat-to-stool comparison rests on even fewer.
Mark
What about the age finding?
Mimi
Under 40, CRP was higher. Forty and over, calprotectin was higher. It showed up in sweat as well as the reference samples.
Luke
Interesting, but nothing here explains why. It's an observation, not a mechanism.
Mark
So what's next?
Mimi
Larger validation, before anyone uses it to guide care.
O Pulso
- A noninvasive skin patch now samples sweat every 60 seconds, offering a possible alternative to repeated blood draws and stool tests for people with IBD.
- Early results from 33 patients show sweat CRP and calprotectin readings broadly tracking serum and stool measurements, but the cohort is small and cross-sectional.
- Marker levels shift with disease type, location, and age, meaning any sweat-based reading would need to be interpreted in context rather than read at face value.
- The study's authors stress that larger validation trials are required before the sensor can be trusted to guide routine clinical care.
Inflammatory bowel disease has long asked patients to give blood and stool samples in order to learn what is happening inside the gut, and a team led by Sarah Shahub has now asked whether the body's sweat might carry the same message. In a small study of 33 people, reported in Inflammatory Bowel Diseases, a patch worn against the skin sampled perspiration and tracked two familiar signals of inflammation, C-reactive protein and calprotectin, and the readings broadly matched what blood and stool tests showed. It is a modest first step, one that hints at a future in which the quiet chemistry of sweat might spare patients some needles and sample jars, though that future has yet to be proven.
A patch worn against the skin, sampling sweat once a minute, has now been put to the test as a way to follow inflammation in people living with inflammatory bowel disease. The study, led by Sarah Shahub, PhD, and colleagues, appears in Inflammatory Bowel Diseases, and it asks a simple but consequential question: can the body's perspiration tell the same story that blood and stool samples tell today?
The device continuously collects sweat and measures C-reactive protein and calprotectin, two markers clinicians already rely on. The researchers compared sweat readings with serum CRP and stool calprotectin in 33 patients, who wore the sensor for 40 to 130 minutes, a window they considered standard for assessment. Stool samples were available only for a subset of participants.
The patterns were revealing. Crohn's disease showed higher CRP than ulcerative colitis, while calprotectin ran higher in ulcerative colitis. Colon involvement was linked to higher calprotectin than isolated ileal disease, and younger patients under 40 carried higher CRP, while those 40 and older showed higher calprotectin.
The investigators concluded that sweat readings were consistent with blood and stool results. They were careful to call this an early signal from a small group, and a sweat sensor will need far larger validation before it can guide everyday IBD care.
A patch worn against the skin, sampling sweat once every 60 seconds, has now been tested as a way to follow inflammation in people with inflammatory bowel disease. The results, from a study led by Sarah Shahub, PhD, and colleagues, appear in Inflammatory Bowel Diseases.
The device is a noninvasive wearable sensor. It continuously collects perspiration and measures two markers that clinicians already use to gauge inflammation in IBD: C-reactive protein, or CRP, and calprotectin. Today those markers are generally read from blood (serum) and stool samples. The question the investigators set out to answer was whether sweat could tell the same story.
The study was cross-sectional and enrolled 33 patients with IBD. For each, the team compared CRP and calprotectin in perspiration collected by the sensor against the same markers measured elsewhere: sweat CRP against serum CRP, and sweat calprotectin against stool calprotectin. Patients wore the sensor for between 40 and 130 minutes, a window the investigators described as the standard of care assessment. Serum samples were collected at the same time. Stool samples for calprotectin came only from a subcohort of the patients.
The researchers also ran a principal component analysis on patient demographic data. Age, diagnosis, and disease activity emerged as major contributors to variance in that dataset. When endoscopic scores were added to the analysis, endoscopy score and disease activity both contributed strongly to the primary variance.
The marker patterns differed by disease type. Patients with Crohn's disease had a higher median CRP than patients with ulcerative colitis, in both perspiration and serum samples. Calprotectin ran the other way, with higher medians in ulcerative colitis than in Crohn's disease.
Location mattered too. IBD affecting the colon was linked to higher median calprotectin in perspiration, stool, and serum than isolated ileal disease.
Age showed a split. Patients younger than 40 had higher median CRP in serum and perspiration than older patients. Patients 40 and older had higher median calprotectin in serum, perspiration, and stool than younger ones.
The investigators concluded that the sensor showed consistency between perspiration CRP and calprotectin measurements and the corresponding serum and stool measurements. This is an early finding from a small cross-sectional group, and larger validation studies would be needed before a sweat sensor could guide routine IBD care.
Citações Notáveis
The sensor showed consistency of perspiration CRP and calprotectin measurements with corresponding serum and stool measurements.— Study investigators, Inflammatory Bowel Diseases
Quer a matéria completa?
Leia o original em DocWireNews ↗
Education